Latest Us Manufacturing News

Page 1 of 6
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.
Victor Sage
Victor Sage
6 Nov 2026
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
Carbonxt is forecasting at least A$22 million of FY27 revenue after securing larger customer orders, but the growth plan remains tied to a delayed Kentucky facility and shareholder approval of a proposed balance sheet restructure. Cash stood at just A$0.7 million after a A$1.0 million operating outflow in the September quarter.
Victor Sage
Victor Sage
30 Oct 2026
Yowie Group has entered FY27 with US$71,000 in cash, a 35% drop in US gross sales and a fully drawn A$4 million working capital facility. The confectionery maker is pursuing an approximately A$6 million two-tranche capital raising while its ASX quotation remains suspended.
Victor Sage
Victor Sage
29 Oct 2026
AML3D has carried $16.8 million of orders into FY27, with its US defence expansion driving a sales pipeline above $80 million. Customer receipts rose 19% in the September quarter, while the company retained $24.42 million in cash to fund capacity expansion.
Victor Sage
Victor Sage
23 Oct 2026
Titomic has secured approval for a US$10.3 million direct loan from the US Export-Import Bank to fund a high-pressure cold-spray production cell in Huntsville, Alabama. The project is expected to expand US manufacturing capacity and support at least dozens of full-time jobs.
Victor Sage
Victor Sage
22 Oct 2026
Boresight Ltd (ASX: BST) used its first quarter after listing to build inventory, expand its US manufacturing footprint and prepare for a larger military order, despite unaudited revenue of about A$829,000. Cash stood at A$5.39 million with no debt after operating outflows of A$2.28 million.
Victor Sage
Victor Sage
19 Oct 2026
Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.
Ada Torres
Ada Torres
29 Sept 2026
Environmental Clean Technologies says its proposed Xenica acquisition has gained a defence-market sublicence for MXenes, adding a potential route to customers for its Flash Joule Heating platform. The agreement is not a customer contract, and revenue still depends on acquisition completion, repeatable production and qualification.
Victor Sage
Victor Sage
14 Sept 2026
Bubs Australia has secured permanent US FDA authorisation for three infant formula products, removing a regulatory barrier in the company’s largest market. The approval supports possible portfolio expansion and contract manufacturing, but the presentation contains no new earnings guidance or quantified financial benefit.
Victor Sage
Victor Sage
10 Sept 2026
Boresight Ltd’s US subsidiary has landed a US$383,275 purchase order from a repeat North American military customer, tripling previous drone orders and expanding its footprint in counter-drone training.
Maxwell Dee
Maxwell Dee
7 Sept 2026

Browse the archive

Full archive